Viewing register:

11 regulatory authorities

Search Medicines & Medical Devices

Curated Report Builder

Select medicine rows from results below to preview a paid report. Quote is based on selected items.

Sign in to unlock report generation

Showing results for "GILOBA NAPI FOR PHARMACEUTICAL INDUSTRIES". Search instead for "GLOBAL NAPI FOR PHARMACEUTICAL INDUSTRIES"

Medicine results for "GLOBAL NAPI FOR PHARMACEUTICAL INDUSTRIES" 5 medicines

0 selected

Price column visibility: locked (sign in required)

Page 1 of 1

	Country	Reg No.	Product Name	Active Ingredient	Manufacturer	Status
	Uganda	NDA/MAL/HDP/10340	BETAMETHASONE DIPROPIONATE + SALICYLIC ACID	-	1. GLOBAL NAPI PHARMACEUTICALS 2ND INDUSTRIAL ZONE, PLOT 40, 18 STREET, 16TH OCTOBER CITY, GIZA 12581 EGYPT SCOPE:COMPLETE MANUFACTURE OF FINISHED PHARMACEUTICAL PRODUCT	Registered	Details →
	Uganda	NDA/MAL/HDP/10335	LIDOCAINE + PRILOCAINE	-	1. GLOBAL NAPI PHARMACEUTICALS 2ND INDUSTRIAL ZONE, PLOT 40, 18 STREET, 16TH OCTOBER CITY, GIZA 12581 EGYPT SCOPE:COMPLETE MANUFACTURE OF FINISHED PHARMACEUTICAL PRODUCT.	Registered	Details →
	Uganda	NDA/MAL/HDP/10691	GABAPENTIN	-	1. GLOBAL NAPI PHARMACEUTICALS 2ND INDUSTRIAL ZONE, PLOT 40, 18 STREET, 16TH OCTOBER CITY, GIZA 12581 EGYPT SCOPE:COMPLETE MANUFACTURE OF FINISHED PHARMACEUTICAL PRODUCT	Registered	Details →
	Uganda	NDA/MAL/HDP/10692	GABAPENTIN	-	1. GLOBAL NAPI PHARMACEUTICALS 2ND INDUSTRIAL ZONE, PLOT 40, 18 STREET, 16TH OCTOBER CITY, GIZA 12581 EGYPT SCOPE:COMPLETE MANUFACTURE OF FINISHED PHARMACEUTICAL PRODUCT	Registered	Details →
	Uganda	NDA/MAL/HDP/10765	PREGABALIN	-	1. GLOBAL NAPI PHARMACEUTICALS 2ND INDUSTRIAL ZONE, PLOT 40, 18 STREET, 16TH OCTOBER CITY, GIZA 12581 EGYPT SCOPE:COMPLETE MANUFACTURE OF FINISHED PHARMACEUTICAL PRODUCT	Registered	Details →

BETAMETHASONE DIPROPIONATE + SALICYLIC ACID

Uganda

NDA/MAL/HDP/10340

Details

LIDOCAINE + PRILOCAINE

Uganda

NDA/MAL/HDP/10335

Details

GABAPENTIN

Uganda

NDA/MAL/HDP/10691

Details

GABAPENTIN

Uganda

NDA/MAL/HDP/10692

Details

PREGABALIN

Uganda

NDA/MAL/HDP/10765

Details